12885_2020_7100_MOESM2_ESM.xlsx (13.56 kB)
Additional file 2 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer
dataset
posted on 2020-07-20, 04:04 authored by Maryam Soleimani Dodaran, Simone Borgoni, Emre Sofyalı, Pernette J. Verschure, Stefan Wiemann, Perry D. Moerland, Antoine H. C. van KampenAdditional file 2. Molecular subtypes. Overview of the molecular subtype frequency as determined by immunohistochemistry of ER and HER2 and as predicted by the SCMOD2 model (R package genefu) using TGCA BRCA primary tumour gene expression data. Subtypes are listed for the 1095 patients for whom gene expression data is available (Fig. 1).
